"Variations in the use of secondary CVD prevention medications over time in our contemporary cohort study suggest little to no improvement globally." HealthDay News — Use of secondary cardiovascular ...

Please provide your email address to receive an email when new articles are posted on . A polypill-based strategy may be cost-effective for primary CVD prevention in historically underserved ...

Broader uptake of single-pill combination (SPC) therapies—polypills—to simplify primary or secondary prevention of cardiovascular disease could have a huge impact on a global scale in the coming ...

This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.

BERKELEY COUNTY, S.C. — Heart disease is the leading cause of death in South Carolina and the United States. That’s why the ...

Boston, MA - A new study demonstrates that providing a multidrug regimen of aspirin, two blood-pressure drugs, and a statin in the developing world is affordable and could have the profound effect of ...

FDA-cleared AI-CVD® extracts preventive insights from routine CT—identifying hidden cardiovascular, metabolic, and ...

Please provide your email address to receive an email when new articles are posted on . Wear Red Day, the first Friday of February, draws attention to the prevalence and dangerousness of heart disease ...

Female reproductive factors minimally impacted cardiovascular disease risk prediction models. Only female-specific factors as a group, not individually, were linked with marginal improvements in risk ...

The problem with daily aspirin use is the risk of bleeding, as seen time and time again in major randomized trials. In the ...